PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
28007523-5	2017	The optimal dose of pinocembrin (5mg/kg) suppressed microglial activation as evidenced by decreases in CD68-positive microglia and reduced proinflammatory cytokines tumor necrosis factor (TNF)-alpha, interleukin (IL)-1beta, and IL-6.	pinocembrin	20-31	interleukin 1 beta	Mus musculus	200-222	
26049009-3	2015	The results showed that pinocembrin dose-dependently inhibited LPS-induced inflammatory mediators TNF-alpha, IL-1beta, NO and PGE2 production.	pinocembrin	24-35	interleukin 1 beta	Mus musculus	109-117	
22713932-3	2012	We found that in vitro pretreatment with pinocembrin remarkably regulated the production of TNF-alpha, IL-1beta, IL-6 and IL-10 via inhibiting the phosphorylation of IkappaBalpha, ERK1/2, JNK and p38MAPK.	pinocembrin	41-52	interleukin 1 beta	Mus musculus	103-111	
23697399-4	2014	The results showed that there was a lower production of TNFalpha, IL-6, and IL-1beta in the serum of LPS-challenged mice that had been pre-treated with pinocembrin.	pinocembrin	152-163	interleukin 1 beta	Mus musculus	76-84